Two popular diabetes drugs outperform others in large clinical trial nejm
in the near-normal range generally have a much lower risk of developing diabetes complications such as nerve, kidney, and eye diseases. Most people with type 2 diabetes require more than one medication to control blood sugar levels over time.combined with diet and exercise is the best early approach in diabetes care, there is no consensus on what to do next to best keep high blood glucose in check.
The study enrolled 5,047 people with type 2 diabetes from diverse racial and ethnic groups who were already taking metformin. Participants were randomly placed into one of four treatment groups. Three groups took metformin plus a medicine that increased insulin levels, sitagliptin, liraglutide, or glimepiride.
"GRADE effectively shows which drugs worked best at achieving and maintaining blood glucose targets over time, but we need to establish even more effective strategies for the long-term maintenance of acceptable glucose levels," said GRADE Study Chair Dr. David M. Nathan, director of the Massachusetts General Hospital Diabetes Center, Boston.
Gastrointestinal symptoms were more common with liraglutide than with the other three treatment groups.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New antiviral mechanism of action for an FDA-approved thiopurine known as 6-thioguanineNew antiviral mechanism of action for an FDA-approved thiopurine known as 6-thioguanine PLOSPathogens DalhousieU UCalgary antiviral virus virology drug treatment
Read more »
'Truly remarkable' drug helps motor neurone diseaseScientists say they have slowed and partially reversed damage, marking a 'new era' in the disease.
Read more »
Novel Nanocarriers to Transport Drug Payloads to the BrainResearchers have formulated a new method for creating drug-delivering nanocarriers, comprising of a soft, fat-like, liposome interior enclosed by a firm shell of gold nanoparticles.
Read more »